New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
216.19+5.31 (+2.52%)
At close: 04:00PM EDT
216.19 0.00 (0.00%)
After hours: 06:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.14B
Enterprise value 13.89B
Trailing P/E 25.40
Forward P/E 20.04
PEG ratio (5-yr expected) 1.70
Price/sales (ttm)2.71
Price/book (mrq)3.06
Enterprise value/revenue 3.38
Enterprise value/EBITDA 13.76

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 33.27%
S&P500 52-week change 324.16%
52-week high 3275.00
52-week low 3161.65
50-day moving average 3215.83
200-day moving average 3219.26

Share statistics

Avg vol (3-month) 3516.54k
Avg vol (10-day) 3453.42k
Shares outstanding 551.51M
Implied shares outstanding 651.51M
Float 850.89M
% held by insiders 10.99%
% held by institutions 1103.05%
Shares short (28 Jun 2024) 41.8M
Short ratio (28 Jun 2024) 43.56
Short % of float (28 Jun 2024) 44.52%
Short % of shares outstanding (28 Jun 2024) 43.49%
Shares short (prior month 31 May 2024) 42.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2023
Most-recent quarter (mrq)30 Mar 2024


Profit margin 10.81%
Operating margin (ttm)14.15%

Management effectiveness

Return on assets (ttm)4.95%
Return on equity (ttm)13.14%

Income statement

Revenue (ttm)4.11B
Revenue per share (ttm)80.13
Quarterly revenue growth (yoy)-1.70%
Gross profit (ttm)N/A
EBITDA 949.58M
Net income avi to common (ttm)444.45M
Diluted EPS (ttm)8.52
Quarterly earnings growth (yoy)-29.30%

Balance sheet

Total cash (mrq)327.04M
Total cash per share (mrq)6.35
Total debt (mrq)3.08B
Total debt/equity (mrq)83.19%
Current ratio (mrq)1.75
Book value per share (mrq)70.67

Cash flow statement

Operating cash flow (ttm)704.4M
Levered free cash flow (ttm)296.32M